The DSM Annual General Meeting of Shareholders on 30 April 2015 passed a resolution to declare a dividend for the financial year 2014 of €1.65 per ordinary share of €1.50 par value. An interim dividend of €0.55 per ordinary share having been paid in August 2014, the final dividend for the financial year 2014 will amount to €1.10 per ordinary share.

This final dividend of €1.10 will be paid out in cash or in the form of ordinary shares at the option of the shareholder. Dividend in cash will be paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on Euronext Amsterdam will be 5 May 2015 and the record date will be 6 May 2015.

Shareholders have from 7 May until 20 May 2015 (3.00 pm CET) to indicate if they wish to receive their dividend in the form of ordinary shares, otherwise it will be distributed in cash. On 21 May 2015 after the close of trading on Euronext Amsterdam the number of dividend rights of ordinary shares entitling the holder to one ordinary share will be determined.

This exchange ratio will be based on the volume weighted average price of all ordinary shares in DSM traded at Euronext Amsterdam on 14 May 2015 up to and including 20 May 2015. The value of the stock dividend will be virtually equal to the value of the cash dividend. The ordinary shares that constitute the stock dividend are entitled to any dividend for the financial year 2015 and to the dividends for subsequent financial years. Stock dividend rights will not be traded on Euronext Amsterdam.

The following timetable applies:
5 May 2015: Ex-dividend quotation
6 May 2015: Record Date
7 May 2015 - 20 May 2015 (3.00 pm CET): Period in which shareholders can indicate their choice
21 May 2015 (COB): Announcement of the exchange ratio
27 May 2015: Delivery of shares or cash payment

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com

DSM announces results of Annual General Meeting of Shareholders

Royal DSM today held its Annual General Meeting of Shareholders at its corporate headquarters in Heerlen (Netherlands). Shareholders approved all resolutions on the agenda.

The following resolutions were approved at the Annual General Meeting of Shareholders:

Adoption of the Financial Statements for 2014
Adoption of the dividend for 2014 (see also separate press release)
Release from liability of the members of the Managing Board in respect of their managerial activities
Release from liability of the members of the Supervisory Board in respect of their supervisory role
Reappointment of Mr. S.B. Tanda as a member of the Managing Board
Reappointment of Mrs. P.F.M. van der Meer Mohr as a member of the Supervisory Board
Extension of the period during which the Managing Board is authorized to issue ordinary shares and to limit or exclude the preferential right when issuing ordinary shares
Authorization of the Managing Board to have the company repurchase shares
Reduction of the issued capital by canceling shares

Furthermore, shareholders were informed that in light of the various cost reduction programs currently being set up in the company, upon request of the Managing Board, the Supervisory Board decided to refrain from an increase in the base salary of members of the Managing Board in 2015.